These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 3047854)

  • 1. The role of antibiotics in Campylobacter pylori associated peptic ulcer disease.
    Bayerdörffer E; Ottenjann R
    Scand J Gastroenterol Suppl; 1988; 142():93-100. PubMed ID: 3047854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibacterial treatment of Campylobacter pylori-associated gastritis and peptic ulcer].
    Andreasen JJ; Ringsdal VS
    Ugeskr Laeger; 1989 Apr; 151(17):1030-3. PubMed ID: 2734863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of Campylobacter pylori in gastroduodenal pathology].
    Sirigu F; Capeccioni S; Dessì A; Masia AM; Usai P
    Recenti Prog Med; 1990 Mar; 81(3):142-5. PubMed ID: 2359867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is Campylobacter pylori the pathogenic agent in gastritis and peptic ulcer?].
    Vráblik V; Trupl J; Pavlovic M; Horváth A; Nespor V
    Vnitr Lek; 1989 Jul; 35(7):672-8. PubMed ID: 2800373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Campylobacter pylori: cause of gastritis and ulcer disease?].
    Gebbers JO; Altermatt HJ; Altorfer J
    Schweiz Med Wochenschr; 1988 Apr; 118(16):577-83. PubMed ID: 3289114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Campylobacter pylori and its role in peptic ulcer disease.
    Tytgat GN; Rauws EA
    Gastroenterol Clin North Am; 1990 Mar; 19(1):183-96. PubMed ID: 2184128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Campylobacter pylori infection in gastric and duodenal ulcer.
    Andreica V; Sască N; Dumitraşcu D; Drăghici A; Pascu O; Sască C; Gorgan V; Ban A
    Med Interne; 1988; 26(4):297-303. PubMed ID: 3244989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What is safe in the treatment of Campylobacter pylori-induced gastritis and Campylobacter pylori-associated peptic ulcer?].
    Menge H
    Internist (Berl); 1988 Nov; 29(11):745-54. PubMed ID: 3069787
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of acid inhibition on Campylobacter pylori.
    Blanco M; Pajares JM; Jimenez ML; Lopez-Brea M
    Scand J Gastroenterol Suppl; 1988; 142():107-9. PubMed ID: 2901784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Campylobacter pyloridis in peptic ulcer].
    Aruin LI; Smotrova IA; Il'chenko AA
    Arkh Patol; 1988; 50(2):13-8. PubMed ID: 3377694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
    Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
    Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy.
    Dooley CP; McKenna D; Humphreys H; Bourke S; Keane CT; Sweeney E; O'Morain C
    Am J Gastroenterol; 1988 Mar; 83(3):278-82. PubMed ID: 3344730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of Helicobacter pylori infection: current status].
    Wagner S; Gebel M; Manns M
    Z Gastroenterol; 1993; 31(7-8):459-63. PubMed ID: 8379235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Campylobacter pylori and pathology of the gastro-duodenal mucosa. Critical review of clinico-experimental and therapeutic contributions].
    Lazzaroni M; Bianchi Porro G
    Medicina (Firenze); 1989; 9(1):9-18. PubMed ID: 2661960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimicrobial drugs in the treatment of stomach and duodenal diseases associated with Campylobacter pylori].
    Perederiĭ VG; Rozhavin MA
    Klin Med (Mosk); 1989 Jan; 67(1):44-8. PubMed ID: 2654463
    [No Abstract]   [Full Text] [Related]  

  • 18. [Has Campylobacter pylori infection any clinical relevance? Methodologic, epidemiologic and clinical studies].
    Döbrönte Z; Lakatos F; Brittig F; Löcsei Z; Bokor N; Stöckert A; Varga L
    Orv Hetil; 1989 Nov; 130(48):2563-8. PubMed ID: 2689946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Campylobacter pylori: its role in gastritis and peptic ulcer disease.
    Hornick RB
    Curr Clin Top Infect Dis; 1989; 10():157-73. PubMed ID: 2679692
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of Helicobacter pylori in peptic ulcer disease.
    O'Connor HJ
    Scand J Gastroenterol Suppl; 1994; 201():11-5. PubMed ID: 8047817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.